Effects of Resveratrol on Nonmelanoma Skin Cancer (NMSC): A Comprehensive Review

ABSTRACT Nonmelanoma skin cancer (NMSC) represents the most prevalent form of skin cancer globally, with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) being the most common types. The search for effective chemopreventive and therapeutic agents has led to the exploration of natural com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food science & nutrition 2024-11, Vol.12 (11), p.8825-8845
Hauptverfasser: Zamanian, Mohammad Yasin, Shahbazi, Taha, Kazmi, Syeda Wajida, Hussien, Beneen M., Sharma, Abhishek, Qasim, Maytham T., Hjazi, Ahmed, Sapaev, Ibrohim B., Nouri Danesh, Ayda, Taheri, Niloofar, Golmohammadi, Maryam
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8845
container_issue 11
container_start_page 8825
container_title Food science & nutrition
container_volume 12
creator Zamanian, Mohammad Yasin
Shahbazi, Taha
Kazmi, Syeda Wajida
Hussien, Beneen M.
Sharma, Abhishek
Qasim, Maytham T.
Hjazi, Ahmed
Sapaev, Ibrohim B.
Nouri Danesh, Ayda
Taheri, Niloofar
Golmohammadi, Maryam
description ABSTRACT Nonmelanoma skin cancer (NMSC) represents the most prevalent form of skin cancer globally, with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) being the most common types. The search for effective chemopreventive and therapeutic agents has led to the exploration of natural compounds, among which resveratrol (RES), a polyphenolic phytoalexin found in grapes, berries, peanuts, and red wine, has garnered significant attention. This comprehensive review aims to elucidate the effects of RES on NMSC, focusing on its mechanisms of action, efficacy in preclinical studies, and potential as a chemopreventive and therapeutic agent. RES exhibits promising chemopreventive and antineoplastic capabilities against NMSC through various mechanisms, including the induction of apoptosis, inhibition of cell proliferation, modulation of oxidative stress, and anti‐inflammatory activities. Studies have demonstrated that RES can significantly enhance the effectiveness of traditional chemotherapeutic agents, such as 5‐fluorouracil (5‐FU), by inhibiting cellular proliferation and inducing apoptosis in cancerous cells. Furthermore, resveratrol's antioxidant properties may mitigate the impact of reactive oxygen species (ROS) triggered by UV exposure, thus reducing DNA damage and mutations associated with skin cancer development. In vitro and in vivo experiments have shown that RES can effectively hinder the growth and spread of various tumor cell types, including human cutaneous SCC A431 cells, and induce apoptosis. The development of advanced delivery systems, such as nanostructured lipid carriers and liposomes, has been recognized for their potential to enhance the therapeutic effects of RES, particularly its anticancer properties. In conclusion, RES presents a viable candidate for the prevention and treatment of NMSC, owing to its multifaceted mechanisms of action, including its ability to regulate oxidative stress, trigger apoptosis, and inhibit proliferation. However, further clinical studies are required to fully understand its effectiveness and safety in humans, as well as to optimize delivery methods for improved bioavailability and therapeutic outcomes. Resveratrol (RES), a natural phytoalexin found in grapes and other plants, has shown promising chemopreventive and antineoplastic properties against nonmelanoma skin cancer (NMSC). It operates through various mechanisms, including the modulation of oxidative stress, induction of apoptosis, and inhibition
doi_str_mv 10.1002/fsn3.4555
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11606877</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3140920278</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3345-5792bbc84c1cde1fdca35c5928762d5685561eb69ba5bbf382bef864147672953</originalsourceid><addsrcrecordid>eNp1kU1PGzEQhq2qCBBw4A9UlrjAIeBv73Kp0IovCVJE2rPldcZl6a6d2kkQ_75OAwgq1RdbmmcezfhFaJ-SY0oIO_E58GMhpfyEthkR1UhTrT-_e2-hvZwfSTm1oIqxTbTFa8VKr9hGd-feg5tnHD2-h7yEZOcp9jgGPI5hgN6GOFg8-dUF3NjgIOHD8e2kOTrFZ7iJwyzBA4TcLaG0Lzt42kUb3vYZ9l7uHfTj4vx7czW6-XZ53ZzdjBznQo6krlnbuko46qZA_dRZLp2sWaUVm0pVSakotKpurWxbzyvWgq-UoEIrzWrJd9DXtXe2aAeYOgjzZHszS91g07OJtjMfK6F7MD_j0lCqiKq0LobDF0OKvxeQ52bosoO-rAxxkQ2ngtSMMF0V9OAf9DEuUij7FYqXXxWc8EIdrSmXYs4J_Ns0lJhVVmaVlVllVdgv78d_I1-TKcDJGnjqenj-v8lcTMb8r_IPcS6cEw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3134164303</pqid></control><display><type>article</type><title>Effects of Resveratrol on Nonmelanoma Skin Cancer (NMSC): A Comprehensive Review</title><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Zamanian, Mohammad Yasin ; Shahbazi, Taha ; Kazmi, Syeda Wajida ; Hussien, Beneen M. ; Sharma, Abhishek ; Qasim, Maytham T. ; Hjazi, Ahmed ; Sapaev, Ibrohim B. ; Nouri Danesh, Ayda ; Taheri, Niloofar ; Golmohammadi, Maryam</creator><creatorcontrib>Zamanian, Mohammad Yasin ; Shahbazi, Taha ; Kazmi, Syeda Wajida ; Hussien, Beneen M. ; Sharma, Abhishek ; Qasim, Maytham T. ; Hjazi, Ahmed ; Sapaev, Ibrohim B. ; Nouri Danesh, Ayda ; Taheri, Niloofar ; Golmohammadi, Maryam</creatorcontrib><description>ABSTRACT Nonmelanoma skin cancer (NMSC) represents the most prevalent form of skin cancer globally, with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) being the most common types. The search for effective chemopreventive and therapeutic agents has led to the exploration of natural compounds, among which resveratrol (RES), a polyphenolic phytoalexin found in grapes, berries, peanuts, and red wine, has garnered significant attention. This comprehensive review aims to elucidate the effects of RES on NMSC, focusing on its mechanisms of action, efficacy in preclinical studies, and potential as a chemopreventive and therapeutic agent. RES exhibits promising chemopreventive and antineoplastic capabilities against NMSC through various mechanisms, including the induction of apoptosis, inhibition of cell proliferation, modulation of oxidative stress, and anti‐inflammatory activities. Studies have demonstrated that RES can significantly enhance the effectiveness of traditional chemotherapeutic agents, such as 5‐fluorouracil (5‐FU), by inhibiting cellular proliferation and inducing apoptosis in cancerous cells. Furthermore, resveratrol's antioxidant properties may mitigate the impact of reactive oxygen species (ROS) triggered by UV exposure, thus reducing DNA damage and mutations associated with skin cancer development. In vitro and in vivo experiments have shown that RES can effectively hinder the growth and spread of various tumor cell types, including human cutaneous SCC A431 cells, and induce apoptosis. The development of advanced delivery systems, such as nanostructured lipid carriers and liposomes, has been recognized for their potential to enhance the therapeutic effects of RES, particularly its anticancer properties. In conclusion, RES presents a viable candidate for the prevention and treatment of NMSC, owing to its multifaceted mechanisms of action, including its ability to regulate oxidative stress, trigger apoptosis, and inhibit proliferation. However, further clinical studies are required to fully understand its effectiveness and safety in humans, as well as to optimize delivery methods for improved bioavailability and therapeutic outcomes. Resveratrol (RES), a natural phytoalexin found in grapes and other plants, has shown promising chemopreventive and antineoplastic properties against nonmelanoma skin cancer (NMSC). It operates through various mechanisms, including the modulation of oxidative stress, induction of apoptosis, and inhibition of cell proliferation. This review highlights the potential of RES, particularly when combined with 5‐fluorouracil (5‐FU) and delivered through advanced lipid–nanocarrier systems, to enhance the effectiveness of NMSC treatments.</description><identifier>ISSN: 2048-7177</identifier><identifier>EISSN: 2048-7177</identifier><identifier>DOI: 10.1002/fsn3.4555</identifier><identifier>PMID: 39620024</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>5-Fluorouracil ; A431 cell line ; Anticancer properties ; Antineoplastic drugs ; Apoptosis ; Basal cell carcinoma ; Bioavailability ; Cancer therapies ; Cell proliferation ; Chemotherapy ; Cytokines ; Dietary guidelines ; DNA damage ; Effectiveness ; Human papillomavirus ; Insulin-like growth factors ; Kinases ; Lipids ; Melanoma ; Mortality ; Mutation ; nonmelanoma skin cancer ; Nutrients ; Oxidative stress ; Pathogenesis ; Pharmacology ; Proteins ; Reactive oxygen species ; Resveratrol ; Review ; Skin cancer ; Squamous cell carcinoma ; Tumor necrosis factor-TNF ; Tumors ; Ultraviolet radiation ; Vascular endothelial growth factor ; Vitamin D ; Wines</subject><ispartof>Food science &amp; nutrition, 2024-11, Vol.12 (11), p.8825-8845</ispartof><rights>2024 The Author(s). published by Wiley Periodicals LLC.</rights><rights>2024 The Author(s). Food Science &amp; Nutrition published by Wiley Periodicals LLC.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3345-5792bbc84c1cde1fdca35c5928762d5685561eb69ba5bbf382bef864147672953</cites><orcidid>0000-0003-0944-0320</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606877/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606877/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39620024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zamanian, Mohammad Yasin</creatorcontrib><creatorcontrib>Shahbazi, Taha</creatorcontrib><creatorcontrib>Kazmi, Syeda Wajida</creatorcontrib><creatorcontrib>Hussien, Beneen M.</creatorcontrib><creatorcontrib>Sharma, Abhishek</creatorcontrib><creatorcontrib>Qasim, Maytham T.</creatorcontrib><creatorcontrib>Hjazi, Ahmed</creatorcontrib><creatorcontrib>Sapaev, Ibrohim B.</creatorcontrib><creatorcontrib>Nouri Danesh, Ayda</creatorcontrib><creatorcontrib>Taheri, Niloofar</creatorcontrib><creatorcontrib>Golmohammadi, Maryam</creatorcontrib><title>Effects of Resveratrol on Nonmelanoma Skin Cancer (NMSC): A Comprehensive Review</title><title>Food science &amp; nutrition</title><addtitle>Food Sci Nutr</addtitle><description>ABSTRACT Nonmelanoma skin cancer (NMSC) represents the most prevalent form of skin cancer globally, with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) being the most common types. The search for effective chemopreventive and therapeutic agents has led to the exploration of natural compounds, among which resveratrol (RES), a polyphenolic phytoalexin found in grapes, berries, peanuts, and red wine, has garnered significant attention. This comprehensive review aims to elucidate the effects of RES on NMSC, focusing on its mechanisms of action, efficacy in preclinical studies, and potential as a chemopreventive and therapeutic agent. RES exhibits promising chemopreventive and antineoplastic capabilities against NMSC through various mechanisms, including the induction of apoptosis, inhibition of cell proliferation, modulation of oxidative stress, and anti‐inflammatory activities. Studies have demonstrated that RES can significantly enhance the effectiveness of traditional chemotherapeutic agents, such as 5‐fluorouracil (5‐FU), by inhibiting cellular proliferation and inducing apoptosis in cancerous cells. Furthermore, resveratrol's antioxidant properties may mitigate the impact of reactive oxygen species (ROS) triggered by UV exposure, thus reducing DNA damage and mutations associated with skin cancer development. In vitro and in vivo experiments have shown that RES can effectively hinder the growth and spread of various tumor cell types, including human cutaneous SCC A431 cells, and induce apoptosis. The development of advanced delivery systems, such as nanostructured lipid carriers and liposomes, has been recognized for their potential to enhance the therapeutic effects of RES, particularly its anticancer properties. In conclusion, RES presents a viable candidate for the prevention and treatment of NMSC, owing to its multifaceted mechanisms of action, including its ability to regulate oxidative stress, trigger apoptosis, and inhibit proliferation. However, further clinical studies are required to fully understand its effectiveness and safety in humans, as well as to optimize delivery methods for improved bioavailability and therapeutic outcomes. Resveratrol (RES), a natural phytoalexin found in grapes and other plants, has shown promising chemopreventive and antineoplastic properties against nonmelanoma skin cancer (NMSC). It operates through various mechanisms, including the modulation of oxidative stress, induction of apoptosis, and inhibition of cell proliferation. This review highlights the potential of RES, particularly when combined with 5‐fluorouracil (5‐FU) and delivered through advanced lipid–nanocarrier systems, to enhance the effectiveness of NMSC treatments.</description><subject>5-Fluorouracil</subject><subject>A431 cell line</subject><subject>Anticancer properties</subject><subject>Antineoplastic drugs</subject><subject>Apoptosis</subject><subject>Basal cell carcinoma</subject><subject>Bioavailability</subject><subject>Cancer therapies</subject><subject>Cell proliferation</subject><subject>Chemotherapy</subject><subject>Cytokines</subject><subject>Dietary guidelines</subject><subject>DNA damage</subject><subject>Effectiveness</subject><subject>Human papillomavirus</subject><subject>Insulin-like growth factors</subject><subject>Kinases</subject><subject>Lipids</subject><subject>Melanoma</subject><subject>Mortality</subject><subject>Mutation</subject><subject>nonmelanoma skin cancer</subject><subject>Nutrients</subject><subject>Oxidative stress</subject><subject>Pathogenesis</subject><subject>Pharmacology</subject><subject>Proteins</subject><subject>Reactive oxygen species</subject><subject>Resveratrol</subject><subject>Review</subject><subject>Skin cancer</subject><subject>Squamous cell carcinoma</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumors</subject><subject>Ultraviolet radiation</subject><subject>Vascular endothelial growth factor</subject><subject>Vitamin D</subject><subject>Wines</subject><issn>2048-7177</issn><issn>2048-7177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kU1PGzEQhq2qCBBw4A9UlrjAIeBv73Kp0IovCVJE2rPldcZl6a6d2kkQ_75OAwgq1RdbmmcezfhFaJ-SY0oIO_E58GMhpfyEthkR1UhTrT-_e2-hvZwfSTm1oIqxTbTFa8VKr9hGd-feg5tnHD2-h7yEZOcp9jgGPI5hgN6GOFg8-dUF3NjgIOHD8e2kOTrFZ7iJwyzBA4TcLaG0Lzt42kUb3vYZ9l7uHfTj4vx7czW6-XZ53ZzdjBznQo6krlnbuko46qZA_dRZLp2sWaUVm0pVSakotKpurWxbzyvWgq-UoEIrzWrJd9DXtXe2aAeYOgjzZHszS91g07OJtjMfK6F7MD_j0lCqiKq0LobDF0OKvxeQ52bosoO-rAxxkQ2ngtSMMF0V9OAf9DEuUij7FYqXXxWc8EIdrSmXYs4J_Ns0lJhVVmaVlVllVdgv78d_I1-TKcDJGnjqenj-v8lcTMb8r_IPcS6cEw</recordid><startdate>202411</startdate><enddate>202411</enddate><creator>Zamanian, Mohammad Yasin</creator><creator>Shahbazi, Taha</creator><creator>Kazmi, Syeda Wajida</creator><creator>Hussien, Beneen M.</creator><creator>Sharma, Abhishek</creator><creator>Qasim, Maytham T.</creator><creator>Hjazi, Ahmed</creator><creator>Sapaev, Ibrohim B.</creator><creator>Nouri Danesh, Ayda</creator><creator>Taheri, Niloofar</creator><creator>Golmohammadi, Maryam</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0944-0320</orcidid></search><sort><creationdate>202411</creationdate><title>Effects of Resveratrol on Nonmelanoma Skin Cancer (NMSC): A Comprehensive Review</title><author>Zamanian, Mohammad Yasin ; Shahbazi, Taha ; Kazmi, Syeda Wajida ; Hussien, Beneen M. ; Sharma, Abhishek ; Qasim, Maytham T. ; Hjazi, Ahmed ; Sapaev, Ibrohim B. ; Nouri Danesh, Ayda ; Taheri, Niloofar ; Golmohammadi, Maryam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3345-5792bbc84c1cde1fdca35c5928762d5685561eb69ba5bbf382bef864147672953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>5-Fluorouracil</topic><topic>A431 cell line</topic><topic>Anticancer properties</topic><topic>Antineoplastic drugs</topic><topic>Apoptosis</topic><topic>Basal cell carcinoma</topic><topic>Bioavailability</topic><topic>Cancer therapies</topic><topic>Cell proliferation</topic><topic>Chemotherapy</topic><topic>Cytokines</topic><topic>Dietary guidelines</topic><topic>DNA damage</topic><topic>Effectiveness</topic><topic>Human papillomavirus</topic><topic>Insulin-like growth factors</topic><topic>Kinases</topic><topic>Lipids</topic><topic>Melanoma</topic><topic>Mortality</topic><topic>Mutation</topic><topic>nonmelanoma skin cancer</topic><topic>Nutrients</topic><topic>Oxidative stress</topic><topic>Pathogenesis</topic><topic>Pharmacology</topic><topic>Proteins</topic><topic>Reactive oxygen species</topic><topic>Resveratrol</topic><topic>Review</topic><topic>Skin cancer</topic><topic>Squamous cell carcinoma</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumors</topic><topic>Ultraviolet radiation</topic><topic>Vascular endothelial growth factor</topic><topic>Vitamin D</topic><topic>Wines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zamanian, Mohammad Yasin</creatorcontrib><creatorcontrib>Shahbazi, Taha</creatorcontrib><creatorcontrib>Kazmi, Syeda Wajida</creatorcontrib><creatorcontrib>Hussien, Beneen M.</creatorcontrib><creatorcontrib>Sharma, Abhishek</creatorcontrib><creatorcontrib>Qasim, Maytham T.</creatorcontrib><creatorcontrib>Hjazi, Ahmed</creatorcontrib><creatorcontrib>Sapaev, Ibrohim B.</creatorcontrib><creatorcontrib>Nouri Danesh, Ayda</creatorcontrib><creatorcontrib>Taheri, Niloofar</creatorcontrib><creatorcontrib>Golmohammadi, Maryam</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Food science &amp; nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zamanian, Mohammad Yasin</au><au>Shahbazi, Taha</au><au>Kazmi, Syeda Wajida</au><au>Hussien, Beneen M.</au><au>Sharma, Abhishek</au><au>Qasim, Maytham T.</au><au>Hjazi, Ahmed</au><au>Sapaev, Ibrohim B.</au><au>Nouri Danesh, Ayda</au><au>Taheri, Niloofar</au><au>Golmohammadi, Maryam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Resveratrol on Nonmelanoma Skin Cancer (NMSC): A Comprehensive Review</atitle><jtitle>Food science &amp; nutrition</jtitle><addtitle>Food Sci Nutr</addtitle><date>2024-11</date><risdate>2024</risdate><volume>12</volume><issue>11</issue><spage>8825</spage><epage>8845</epage><pages>8825-8845</pages><issn>2048-7177</issn><eissn>2048-7177</eissn><abstract>ABSTRACT Nonmelanoma skin cancer (NMSC) represents the most prevalent form of skin cancer globally, with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) being the most common types. The search for effective chemopreventive and therapeutic agents has led to the exploration of natural compounds, among which resveratrol (RES), a polyphenolic phytoalexin found in grapes, berries, peanuts, and red wine, has garnered significant attention. This comprehensive review aims to elucidate the effects of RES on NMSC, focusing on its mechanisms of action, efficacy in preclinical studies, and potential as a chemopreventive and therapeutic agent. RES exhibits promising chemopreventive and antineoplastic capabilities against NMSC through various mechanisms, including the induction of apoptosis, inhibition of cell proliferation, modulation of oxidative stress, and anti‐inflammatory activities. Studies have demonstrated that RES can significantly enhance the effectiveness of traditional chemotherapeutic agents, such as 5‐fluorouracil (5‐FU), by inhibiting cellular proliferation and inducing apoptosis in cancerous cells. Furthermore, resveratrol's antioxidant properties may mitigate the impact of reactive oxygen species (ROS) triggered by UV exposure, thus reducing DNA damage and mutations associated with skin cancer development. In vitro and in vivo experiments have shown that RES can effectively hinder the growth and spread of various tumor cell types, including human cutaneous SCC A431 cells, and induce apoptosis. The development of advanced delivery systems, such as nanostructured lipid carriers and liposomes, has been recognized for their potential to enhance the therapeutic effects of RES, particularly its anticancer properties. In conclusion, RES presents a viable candidate for the prevention and treatment of NMSC, owing to its multifaceted mechanisms of action, including its ability to regulate oxidative stress, trigger apoptosis, and inhibit proliferation. However, further clinical studies are required to fully understand its effectiveness and safety in humans, as well as to optimize delivery methods for improved bioavailability and therapeutic outcomes. Resveratrol (RES), a natural phytoalexin found in grapes and other plants, has shown promising chemopreventive and antineoplastic properties against nonmelanoma skin cancer (NMSC). It operates through various mechanisms, including the modulation of oxidative stress, induction of apoptosis, and inhibition of cell proliferation. This review highlights the potential of RES, particularly when combined with 5‐fluorouracil (5‐FU) and delivered through advanced lipid–nanocarrier systems, to enhance the effectiveness of NMSC treatments.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>39620024</pmid><doi>10.1002/fsn3.4555</doi><tpages>21</tpages><orcidid>https://orcid.org/0000-0003-0944-0320</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2048-7177
ispartof Food science & nutrition, 2024-11, Vol.12 (11), p.8825-8845
issn 2048-7177
2048-7177
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11606877
source Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central
subjects 5-Fluorouracil
A431 cell line
Anticancer properties
Antineoplastic drugs
Apoptosis
Basal cell carcinoma
Bioavailability
Cancer therapies
Cell proliferation
Chemotherapy
Cytokines
Dietary guidelines
DNA damage
Effectiveness
Human papillomavirus
Insulin-like growth factors
Kinases
Lipids
Melanoma
Mortality
Mutation
nonmelanoma skin cancer
Nutrients
Oxidative stress
Pathogenesis
Pharmacology
Proteins
Reactive oxygen species
Resveratrol
Review
Skin cancer
Squamous cell carcinoma
Tumor necrosis factor-TNF
Tumors
Ultraviolet radiation
Vascular endothelial growth factor
Vitamin D
Wines
title Effects of Resveratrol on Nonmelanoma Skin Cancer (NMSC): A Comprehensive Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T21%3A12%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Resveratrol%20on%20Nonmelanoma%20Skin%20Cancer%20(NMSC):%20A%20Comprehensive%20Review&rft.jtitle=Food%20science%20&%20nutrition&rft.au=Zamanian,%20Mohammad%C2%A0Yasin&rft.date=2024-11&rft.volume=12&rft.issue=11&rft.spage=8825&rft.epage=8845&rft.pages=8825-8845&rft.issn=2048-7177&rft.eissn=2048-7177&rft_id=info:doi/10.1002/fsn3.4555&rft_dat=%3Cproquest_pubme%3E3140920278%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3134164303&rft_id=info:pmid/39620024&rfr_iscdi=true